About Nitto denko avecia inc.
Nitto Avecia Inc. is a leading manufacturer of oligonucleotide therapeutics, providing end-to-end support from pre-clinical development through commercial launch. The company has been in the industry for over 20 years and has established itself as a trusted partner for pharmaceutical and biotech companies worldwide.
One of the key strengths of Nitto Avecia is its expertise in oligonucleotide synthesis, purification, and formulation. The company's state-of-the-art facilities are equipped with cutting-edge technologies that enable it to produce high-quality oligonucleotides at scale. Nitto Avecia's team of scientists and engineers are highly skilled in their respective fields, ensuring that every project is executed with precision and accuracy.
Nitto Avecia offers a wide range of services to its clients, including custom oligo synthesis, process development, analytical testing, GMP manufacturing, and regulatory support. The company's comprehensive approach ensures that clients receive tailored solutions that meet their specific needs.
One area where Nitto Avecia excels is in its ability to provide end-to-end support for clients throughout the drug development process. From early-stage research to clinical trials to commercial launch, Nitto Avecia works closely with clients every step of the way to ensure success.
The company's pre-clinical services include custom oligo synthesis for research purposes as well as process development and optimization for scale-up production. Nitto Avecia also offers analytical testing services such as HPLC analysis and mass spectrometry to ensure product quality.
For clinical trials, Nitto Avecia provides GMP manufacturing services using its state-of-the-art facilities that comply with FDA regulations. The company also offers regulatory support services such as IND/IMPD filing assistance and DMF preparation.
Once a drug candidate reaches commercialization stage, Nitto Avecia can provide large-scale GMP manufacturing capabilities along with supply chain management solutions to ensure timely delivery of products worldwide.
In addition to its core business offerings, Nitto Avecia also invests heavily in R&D activities aimed at advancing the field of oligonucleotide therapeutics. The company collaborates with academic institutions and industry partners on various projects aimed at developing new technologies or improving existing ones.
Overall, Nitto denko avecia inc.'s commitment towards innovation combined with its extensive experience makes it an ideal partner for pharmaceutical companies looking for reliable end-to-end solutions in the field of oligonucleotide therapeutics."
avecia.com
